Literature DB >> 20154334

The rise and fall of rosiglitazone.

Steven E Nissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20154334     DOI： 10.1093/eurheartj/ehq016

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  [Cardial target-organ damage in diabetes].

Authors:  W Motz; W Kerner
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

2.  Research ethics. Rethinking research ethics: the case of postmarketing trials.

Authors:  Alex John London; Jonathan Kimmelman; Benjamin Carlisle
Journal:  Science       Date:  2012-05-04       Impact factor: 47.728

3.  Interpreting Clinical Trial Outcomes for Optimal Patient Care: A Survey of Clinicians and Trainees.

Authors:  Tanner J Caverly; Daniel D Matlock; Allan V Prochazka; Brian P Lucas; Rodney A Hayward
Journal:  J Grad Med Educ       Date:  2016-02

Review 4.  After avandia: the use of antidiabetic drugs in patients with heart failure.

Authors:  Khaled I Khalaf; Heinrich Taegtmeyer
Journal:  Tex Heart Inst J       Date:  2012

5.  Developing therapies for the metabolic syndrome: challenges, opportunities, and… the unknown.

Authors:  Glenn Matfin
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

6.  Insulin sensitizers and heart failure: an engine flooded with fuel.

Authors:  Khaled I Khalaf; Heinrich Taegtmeyer
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

7.  Therapy: The second time as farce: rosiglitazone and the regulators.

Authors:  Edwin A M Gale
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

Review 8.  Metabolic implications of pancreatic fat accumulation.

Authors:  Robert Wagner; Sabine S Eckstein; Hajime Yamazaki; Felicia Gerst; Jürgen Machann; Benjamin Assad Jaghutriz; Annette Schürmann; Michele Solimena; Stephan Singer; Alfred Königsrainer; Andreas L Birkenfeld; Hans-Ulrich Häring; Andreas Fritsche; Susanne Ullrich; Martin Heni
Journal:  Nat Rev Endocrinol       Date:  2021-10-20       Impact factor: 43.330

9.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

10.  Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.

Authors:  Saumya Reddy Kankanala; Rafay Syed; Quan Gong; Boxu Ren; Xiaoquan Rao; Jixin Zhong
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.